- Report
- August 2024
- 200 Pages
Global
From €3692EUR$3,869USD£3,094GBP
- Report
- August 2024
- 200 Pages
Global
From €3692EUR$3,869USD£3,094GBP
- Report
- August 2024
- 200 Pages
Global
From €3692EUR$3,869USD£3,094GBP
- Report
- August 2024
- 200 Pages
Global
From €3692EUR$3,869USD£3,094GBP
- Report
- August 2024
- 200 Pages
Global
From €4723EUR$4,949USD£3,957GBP
- Report
- August 2024
- 200 Pages
Global
From €4723EUR$4,949USD£3,957GBP
- Report
- July 2024
- 200 Pages
Global
From €4723EUR$4,949USD£3,957GBP
- Report
- April 2024
- 140 Pages
Global
From €4723EUR$4,949USD£3,957GBP
- Report
- January 2025
- 191 Pages
Global
From €4767EUR$4,995USD£3,994GBP
- Report
- June 2024
- 250 Pages
Global
From €4767EUR$4,995USD£3,994GBP
- Report
- May 2024
- 277 Pages
Global
From €4767EUR$4,995USD£3,994GBP
- Report
- December 2024
- 150 Pages
Global
From €3770EUR$3,950USD£3,159GBP
- Report
- December 2024
- 150 Pages
Global
From €3770EUR$3,950USD£3,159GBP
- Report
- December 2024
- 150 Pages
Global
From €3770EUR$3,950USD£3,159GBP
- Report
- July 2024
- 153 Pages
Global
From €4056EUR$4,250USD£3,398GBP
- Conference
- March 2025
- 5 Days
Global
€2346EUR$2,544USD£1,899GBP
- Conference
- November 2025
- 5 Days
Global
€1975EUR$2,142USD£1,599GBP
€2346EUR$2,544USD£1,899GBP
- Conference
- May 2025
- 2 Days
Global
- Report
- March 2025
- 84 Pages
Global
From €5345EUR$5,600USD£4,478GBP
- Report
- March 2025
- 196 Pages
Global
From €4724EUR$4,950USD£3,958GBP

Biomedicine is a branch of biotechnology that focuses on the development of medical treatments and products. It involves the use of living organisms, such as bacteria, viruses, and cells, to create treatments and products that can be used to diagnose, prevent, and treat diseases. Biomedicine also includes the development of medical devices, such as prosthetics, and the use of genetic engineering to create new treatments.
Biomedicine is a rapidly growing field, with many companies investing in research and development. Companies in the biomedicine market are focused on developing treatments and products for a variety of diseases, including cancer, diabetes, and cardiovascular diseases. They are also working to develop treatments for rare diseases and to improve existing treatments.
Some of the companies in the biomedicine market include AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Celgene, Gilead Sciences, Johnson & Johnson, Merck, Novartis, Pfizer, and Roche. Show Less Read more